Nicotinic acid plasma concentrations after ingestion of 1,3,4,6-tetranicotinoyl-fructo-furanose (tetranicotinoylfructose, nicofuranose).
D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D005632:Fructose / Q000008:administration & dosage* / Q000009:adverse effects; D005663:Furans / Q000009:adverse effects; D006801:Humans; D008297:Male; D009538:Nicotine / Q000008:administration & dosage* / Q000009:adverse effects; D009539:Nicotinic Acids / Q000097:blood*; D012907:Smoking; D013607:Tablets; D013608:Tablets, Enteric-Coated; D013997:Time Factors
D005663:Furans; D009539:Nicotinic Acids; D013607:Tablets; D013608:Tablets, Enteric-Coated; D005632:Fructose; D009538:Nicotine